Releases


All 2016 Releases
Nov 17, 2016 Veloxis Pharmaceuticals A/S Establishes New Warrant Programme PDF 228.8 KB Add to Briefcase
Nov 16, 2016 Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2016 and Provides Corporate Update PDF 774.1 KB Add to Briefcase
Sep 30, 2016 Veloxis Announces the Total Number of Shares and Voting Rights PDF 285.7 KB Add to Briefcase
Sep 20, 2016 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 278.9 KB Add to Briefcase
Sep 6, 2016 Veloxis Increases Share Capital in Connection with Exercise of Warrants PDF 279.3 KB Add to Briefcase
Aug 31, 2016 Veloxis Pharmaceuticals A/S Completes Closure of its Hørsholm, Denmark Office PDF 225.9 KB Add to Briefcase
Aug 25, 2016 Veloxis Pharmaceuticals A/S Establishes New Warrant Programme PDF 307.7 KB Add to Briefcase
Aug 24, 2016 Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2016 and Provides Corporate Update PDF 781.6 KB Add to Briefcase
Jul 26, 2016 Veloxis Pharmaceuticals A/S - Passing of Extraordinary General Meeting PDF 358.3 KB Add to Briefcase
Jul 1, 2016 Notice to Convene Extraordinary General Meeting PDF 168.5 KB Add to Briefcase
Jun 30, 2016 Veloxis announces the total number of shares and voting rights in the company as of 30 June 2016 PDF 208.0 KB Add to Briefcase
Jun 29, 2016 Veloxis Receives Envarsus XR® Package Insert Label Enhancements Based on Study of African-American Transplant Recipients PDF 322.5 KB Add to Briefcase
Jun 13, 2016 Veloxis increases share capital in connection with exercise of warrants  
Jun 8, 2016 Veloxis to Present Company Overview and Envarus® XR (tacrolimus extended-release tablets) Launch Update at Jefferies 2016 Healthcare Conference  
May 31, 2016 Veloxis announces the total number of shares and voting rights in the company as of 31 May 2016  
May 30, 2016 Veloxis increases share capital in connection with exercise of warrants  
May 19, 2016 Veloxis Pharmaceuticals A/S establishes new Warrant Programme  
May 18, 2016 Veloxis Pharmaceuticals announces financial results for the first three months of 2016  
May 11, 2016 Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for the first Quarter 2016 — results from 1 January to 31 March, 2016  
Apr 7, 2016 Veloxis Pharmaceuticals A/S establishes new Warrant Programme  
Apr 6, 2016 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting  
Apr 6, 2016 Veloxis announces change in management  
Apr 6, 2016 Veloxis offentliggør ændring af ledelsen  
Mar 31, 2016 Veloxis announces the total number of shares and voting rights in the company as of 31 March 2016  
Mar 31, 2016 Veloxis annoncerer det samlede antal aktier og stemmerettigheder i selskabet pr. 31. marts 2016  
Mar 30, 2016 Veloxis udsteder nye aktier i forbindelse med udnyttelse af warrants  
Mar 30, 2016 Veloxis increases share capital in connection with exercise of warrants  
Mar 15, 2016 Notice to Convene Annual General Meeting  
Mar 15, 2016 Indkaldelse til ordinær generalforsamling  
Mar 9, 2016 Veloxis Pharmaceuticals offentliggør årsrapport 2015  
Mar 9, 2016 Veloxis Pharmaceuticals publishes Annual Report 2015  
Mar 9, 2016 Veloxis Pharmaceuticals A/S moves Danish activates to the U.S.  
Mar 2, 2016 Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Annual report 2015 — results from 1 January to 31 December, 2015  
Mar 2, 2016 Veloxis Pharmaceuticals A/S er vært for en telekonference i forbindelse med offentliggørelsen af årsrapporten 2015 — resultater fra 1. januar til 31. december 2015  
Feb 29, 2016 Veloxis appoints Alastair McEwan as new Chief Operating Officer  
Feb 29, 2016 Veloxis udnævner Alastair McEwan til ny Chief Operating Officer  
Showing 1-36 of 36 Page: 1  
=add release to Briefcase